PNC Financial Services Group
MIRM icon

PNC Financial Services Group’s Mirum Pharmaceuticals MIRM Stock Holding History

PNC Financial Services Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Buy
1,589
+233
+17% +$23.4K ﹤0.01% 2507
2026
Q1 		$125K Buy
1,356
+744
+122% +$70K ﹤0.01% 2662
2025
Q4 		$48.3K Sell
612
-650
-52% -$46.7K ﹤0.01% 3231
2025
Q3 		$92.5K Buy
1,262
+817
+184% +$51.9K ﹤0.01% 2853
2025
Q2 		$22.6K Sell
445
-8
-2% -$356 ﹤0.01% 3513
2025
Q1 		$20.4K Buy
453
+282
+165% +$13.3K ﹤0.01% 3529
2024
Q4 		$7.07K Sell
171
-52
-23% -$2.17K ﹤0.01% 3923
2024
Q3 		$8.7K Buy
223
+132
+145% +$5.27K ﹤0.01% 3850
2024
Q2 		$3.11K Sell
91
-46
-34% -$1.21K ﹤0.01% 4129
2024
Q1 		$3.44K Buy
137
+96
+234% +$2.64K ﹤0.01% 4062
2023
Q4 		$1.21K Buy
41
+26
+173% +$787 ﹤0.01% 4285
2023
Q3 		$474 Hold
15
– – ﹤0.01% 4468
2023
Q2 		$388 Buy
+15
New +$399 ﹤0.01% 4612
2023
Q1 		– Sell
-18
Closed -$351 – 4772
2022
Q4 		$351 Hold
18
– – ﹤0.01% 4575
2022
Q3 		$0 Hold
18
– – ﹤0.01% 4548
2022
Q2 		$0 Buy
+18
New +$425 ﹤0.01% 4629

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's MIRM Position: Q2 2026 in Review

PNC Financial Services Group increased its Mirum Pharmaceuticals (MIRM) stake by 17% in Q2 2026, buying an estimated $23.4K and bringing the position to 1,589 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #2507.

PNC Financial Services Group first reported a position in MIRM in Q2 2022 and has held it in 16 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • PNC Financial Services Group held 1,589 shares of Mirum Pharmaceuticals worth $186K as of Q2 2026.
  • PNC Financial Services Group bought 233 Mirum Pharmaceuticals shares in Q2 2026, an estimated $23.4K.
  • Mirum Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2507 holding.
  • PNC Financial Services Group first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.